Science publication on a breakthrough methodological development
Erlend Strønen, Johanna Olweus and the Immunotherapy Jebsen Center team’s work on a breakthrough methodological development in generating broad and tumour-specific T-cell immune responses has been published in Science. The work is based on a novel allogeneic approach. This is a powerful technological development which can in the relatively near future be subjected to clinical testing.
